Gammagard s-d 10 g (IGA
Ended Awarded Last action
- Contract number
- SPE2DR26F9KR6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,640
Award facts
- Contract value 100% obligated
- $10,639.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,639.70 to AmerisourceBergen Drug Corp for the supply of Gammagard S-D 10G, a critical immunological therapeutic product. This non-set-aside, firm fixed-price delivery order was awarded on January 12, 2026, with an ultimate completion date of February 3, 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a task order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at up to $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. (which operates under the doing business as name AmerisourceBergen), is a major pharmaceutical distributor and healthcare solutions provider that supplies a comprehensive range of medical products to federal agencies. The parent company, Cencora, Inc., holds a significant IDC with the Defense Logistics Agency valued at up to $999,999,999.00 through December 31, 2031. Both entities compete on a full and open basis for federal contracts without set-aside designations, demonstrating their capability to meet competitive federal procurement requirements. These contracts position AmerisourceBergen as a critical vendor for supporting military healthcare systems, the Defense Health Agency, and other government medical institutions with essential pharmaceutical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F9KR6?
SPE2DR26F9KR6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F9KR6 worth?
The government has obligated $10,640 on SPE2DR26F9KR6.
Is contract SPE2DR26F9KR6 an order under another contract?
Yes. SPE2DR26F9KR6 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9KR6 competed?
The extent of competition for SPE2DR26F9KR6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award